Drugmakers Spending Two-Fifths Of Sales On Marketing

South Korea's drug companies spend over 40% of turnover on promotional, advertising and marketing activities. This contradicts one of BMI's core views for the pharmaceutical and healthcare industry: branding will become more important, but spending on advertising will decrease. However, we note that regulators in the Asian country are increasingly looking to eliminate kickbacks, bribes and excessive

To read the full article, please choose one of the following options: